Coegin Pharma Investor Relations Material
Latest events
Status Update
Coegin Pharma
Q2 2025
21 Aug, 2025
Q1 2025
22 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Coegin Pharma
Access all reports
Coegin Pharma AB is a Sweden-based biotechnology company focused on developing innovative therapies for inflammatory-driven diseases. The company leverages its expertise in molecular targeting to develop pharmaceutical candidates addressing conditions such as cancer, fibrosis, and chronic inflammation. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
COEGIN
Country
🇸🇪 Sweden